FDA Approves Unknown Drug — ACTAVIS INC
On April 11, 2016, ACTAVIS INC received FDA approval for its Abbreviated New Drug Application # ANDA204549, marking the first approval of a generic biologic and signaling a potential surge in competition for biosimilars in the growing market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed